PREPAIRE Trademark

Trademark Overview


On Wednesday, December 22, 2021, a trademark application was filed for PREPAIRE with the United States Patent and Trademark Office. The USPTO has given the PREPAIRE trademark a serial number of 97184717. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2023. This trademark is owned by AiPharma Development LLC. The PREPAIRE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; Pharmaceutical research services; Research on the subject of pharmaceuticals; Technical research in the field of pharmaceutical studies; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Development of pharmaceutical preparations and medicines; Development of pharmaceutical preparations, used internally as pills and other solids, and also used as sprays and liquids, for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical product evaluation
prepaire

General Information


Serial Number97184717
Word MarkPREPAIRE
Filing DateWednesday, December 22, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements


Description of MarkThe mark consists of a stylized shield with a cross at the left top corner located behind the letters "PR" in the wording "PREPAIRE".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDrug discovery services; Pharmaceutical research services; Research on the subject of pharmaceuticals; Technical research in the field of pharmaceutical studies; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Development of pharmaceutical preparations and medicines; Development of pharmaceutical preparations, used internally as pills and other solids, and also used as sprays and liquids, for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical product evaluation

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 28, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAiPharma Development LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDubai
AE

Party NameAiPharma Development LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDubai
AE

Trademark Events


Event DateEvent Description
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 1, 2022ASSIGNED TO LIE
Wednesday, August 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 27, 2022NON-FINAL ACTION E-MAILED
Monday, June 27, 2022NON-FINAL ACTION WRITTEN
Friday, June 24, 2022ASSIGNED TO EXAMINER
Wednesday, December 29, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 25, 2021NEW APPLICATION ENTERED